Table 1

Patient characteristics

 Delayed cerebral ischaemiaPoor outcome
No (n=155)Yes (n=97)No (n=94)Yes (n=108)
Demographics
 Age, years57.1±14.156.0±13.553.1±12.060.5±15.6
 Gender, male47 (30.3)26 (26.8)34 (36.2)28 (25.9)
 Ethnicity, white68 (43.9)41 (42.3)45 (47.9)51 (47.2)
Risk factors and comorbidities
 Hypertension85 (54.8)46 (47.4)46 (48.9)56 (51.9)
 Smoking61 (39.4)34 (35.1)40 (42.6)29 (26.9)
 Alcohol14 (9.0)11 (11.3)12 (12.8)6 (5.6)
 Stroke12 (7.7)4 (4.1)3 (3.2)11 (10.2)
 Cardiac disease16 (10.3)8 (8.2)4 (4.3)17 (15.7)
 Pulmonary disease10 (6.5)4 (4.1)6 (6.4)7 (6.5)
Initial assessment
 GCS8 (6–10)8 (6–10)9 (7–14)7 (5–10)
 Hunt–Hess grade
  15 (3.2)4 (4.1)8 (8.5)1 (0.9)
  27 (4.5)3 (3.1)7 (7.4)1 (0.9)
  341 (26.5)23 (23.7)24 (25.5)28 (25.9)
  464 (41.3)44 (45.4)41 (43.6)41 (38.0)
  538 (24.5)23 (23.7)14 (14.9)37 (34.3)
 Modified Fisher scale
  119 (12.3)6 (6.2)7 (7.4)12 (11.1)
  221 (13.5)7 (7.2)12 (12.8)12 (11.1)
  363 (40.6)40 (41.2)38 (40.4)42 (38.9)
  452 (33.5)44 (45.4)37 (39.4)42 (38.9)
 Hijdra scale18.3±7.419.8±8.418.8±7.718.6±7.8
 Global cerebral oedema, initial CT41 (26.5)32 (33.0)26 (27.7)28 (25.9)
 Aneurysm size, mm8.7±6.78.0±4.57.5±3.99.9±7.5
 APACHE II score17.5±7.018.0±6.216.2±6.519.3±6.7
Follow-up assessment
 Rebleeding20 (12.9)21 (21.6)8 (8.5)24 (22.2)
 Global cerebral oedema, follow-up CT111 (71.6)85 (87.6)60 (63.8)92 (85.2)
 Hydrocephalus110 (71.0)74 (76.3)64 (68.1)85 (78.7)
 Intracranial pressure crisis95 (61.3)75 (77.3)61 (64.9)74 (68.5)
 Meningitis25 (16.1)20 (20.6)14 (14.9)25 (23.1)
 Pneumonia and/or pulmonary oedema96 (61.9)73 (75.3)55 (58.5)84 (77.8)
 Sepsis28 (18.1)28 (28.9)12 (12.8)28 (25.9)
Exposure to hyperoxia28 (18.1)36 (37.1)18 (19.1)32 (29.6)
Exposure to hypocarbia25 (16.1)23 (23.7)15 (16.0)21 (19.4)
  • Values are number (column %), mean±SD, or median (IQR), as appropriate.

  • APACHE II, Acute Physiology and Chronic Health Evaluation II; GCS, Glasgow coma scale.